Clinical Trials Browser

Phase 3 × Lymphoma, Extranodal NK-T-Cell × Cyclophosphamide × Clear all

NCT02359162 2018-05-09

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Phase 3 Terminated

Lymphoma, Extranodal NK-T-Cell